Close Menu

NEW YORK (GenomeWeb) – Natera announced today that it has prices its $100 million common stock offering.

The San Carlos, California-based molecular diagnostics firm is offering 5,263,158 shares of common stock at $19 per share. Gross proceeds from the offering would be $100 million, however, the underwriters of the transaction have a 30-day option to purchase an additional 789,473 shares at the offering price.

JP Morgan, Cowen, and Piper Jaffray are acting as joint book-running managers for the offering. Baird and Canaccord Genuity are listed as co-managers for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.